Evidence map›Paper›PMID 30886699›Full record

ArticleTherapeutic advances in psychopharmacology2019

Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques.

Michael Ott, Julie K Mannchen, Fariba Jamshidi, Ursula Werneke

Open access · goldAbstract readCase Reports
In one paragraph

Article in Therapeutic advances in psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Antidepressant Drugs Effects on Blood Pressure.Frontiers in cardiovascular medicine · 2021
    Review
  8. Article
  9. Psychiatric Medications and Hypertension.Current hypertension reports · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Michael OttDepartment of Public Health and Clinical Medicine - Medicine, Umeå University, 901 87 Umeå, Sweden.ORCID https://orcid.org/0000-0003-2393-9750
Julie K MannchenDepartment of Public Health and Clinical Medicine - Family Medicine, Umeå University, Umeå, Sweden.
Fariba JamshidiSunderby Hospital, Luleå, Sweden.
Ursula WernekeSunderby Research Unit, Department of Clinical Sciences - Psychiatry, Umeå University, Umeå, Sweden.
Umeå University · SESunderby sjukhus · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin syndrome is thought to arise from serotonin excess. In many cases, symptoms are mild and self-limiting. But serotonin syndrome can become life threatening, when neuromuscular hyperexcitability spins out of control. Uncontainable neuromuscular hyperexcitability may lead to cardiovascular complications, linked to extreme changes in blood pressure. Currently, there is little guidance on how to control blood pressure in hyperserotonergic states. We report a case with treatment-resistant arterial hypertension, followed by a clinical review (using systematic review principles and techniques) of the available evidence from case reports published between 2004 and 2016 to identify measures to control arterial hypertension associated with serotonin syndrome. We conclude that classic antihypertensives may not be effective for the treatment of severe hypertension associated with serotonin syndrome. Benzodiazepines may lower blood pressure. Patients with severe hypertension not responding to benzodiazepines may benefit from cyproheptadine, propofol or both. In severe cases, higher cyproheptadine doses than currently recommended may be necessary.

Indexed as

antihypertensive agentsarterial hypertensioncyproheptadinehypertensionpropofolserotonin antagonistsserotonin syndrome

Identifiers

PMID30886699
PMCPMC6413434
OpenAlexW2921998603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.